Health
A new daily oral drug shows promise against pancreatic cancer, shrinking or eliminating tumours
A short report compiled from 2 newspapers.
Conflicting reportsTrust meter0%
- 86% One paper only, unverified
- 14% Papers differ
Based on 7 facts in the story. The bigger the green part, the more papers wrote the same thing. It measures agreement between papers, not independent verification.
2 newspapers
Published 22 November 2026, 08:28

According to Jagonews24 and The Business Standard, A new daily oral drug shows promise against pancreatic cancer, shrinking or eliminating tumours.
The Business Standard names: The new drug named 'daraxonrasib' (tbsnews).
According to The Business Standard, Advanced-stage patients per group in which tumour disappeared (1 in 12) 12.
According to Jagonews24 and The Business Standard, The drug is a pill taken once daily.
According to Jagonews24, Could be the biggest advance in pancreatic cancer treatment in decades.
According to The Business Standard, Pancreatic cancer is among the deadliest cancers.
According to The Business Standard, Pancreatic cancer is generally considered a 'silent killer'.
According to The Business Standard, In research, the pill taken alongside chemotherapy showed results in advanced-stage patients.
According to Jagonews24, Per jagonews24, in experimental use some patients' tumours shrank.
Mismatch
| Topic | Jagonews24 | TBS |
|---|---|---|
| what happened | কয়েকজন রোগীর টিউমার ছোট হয়েছে | টিউমার পুরোপুরি মিলিয়ে গেছে |
QuickPost assessment
Conflicting reports — Papers give materially different accounts of some details.
Last assessed: 22 November 2026, 08:28
- What was reported
- 2 papers reported this: Jagonews24 and TBS.
- Supported by more than one paper
- 0 details.
- Reported by one paper only — unverified
- 6 details, credited to the paper that reported them.
- Where the papers differ
- 1 point differ — see the comparison.Comparison →
- What is still missing
- No official statement or document found yet.
- No direct statement from the people involved in the reports we could read.
What would help: another paper's report, an official statement or document, or a first-hand account. We update this story when reliable new evidence arrives.
Send information or a correction →How this comparison is madeFact check by fact
Which paper gave each fact, and where they agree or differ.
- 1
what happened
- Jagonews24: কয়েকজন রোগীর টিউমার ছোট হয়েছে
- TBS: টিউমার পুরোপুরি মিলিয়ে গেছে
Papers differJagonews24, TBS
- 2
Could be the biggest advance in pancreatic cancer treatment in decades
One paper only, unverifiedJagonews24
- 3
Pancreatic cancer is among the deadliest cancers
One paper only, unverifiedTBS
- 4
Pancreatic cancer is generally considered a 'silent killer'
One paper only, unverifiedTBS
- 5
In research, the pill taken alongside chemotherapy showed results in advanced-stage patients
One paper only, unverifiedTBS
- 6
Per jagonews24, in experimental use some patients' tumours shrank
One paper only, unverifiedJagonews24
- 7
Advanced-stage patients per group in which tumour disappeared (1 in 12) 12
One paper only, unverifiedTBS
Copies of the same report count once, not as separate confirmation. The graph updates when new evidence arrives.
Help Us Establish the Facts
Are you directly involved in this story, a journalist covering the event, an eyewitness or someone with relevant information?
Do you believe the original newspaper's reporting or QuickPost's assessment is inaccurate, incomplete or misleading?
Your contribution is received and assessed confidentially. QuickPost will update this story when reliable new evidence becomes available. Your identity will not be published without your explicit consent.